FP7 takes off

The EU's largest ever funding programme for research and technological development, the Seventh Framework Programme (FP7), was launched on 1 January.

The programme cleared its final hurdle when it was adopted by the Council on 18 December 2006. The decision was widely expected following an agreement on a common position between the Parliament and Council in November. The common position meant that the decision could be adopted by the Environment Council without discussion.

With a total budget of €50.521 billion, FP7 will run for of seven years. An additional €2.7 billion has been earmarked for the Euratom programme on nuclear research, which will run for five years. EU Science and Research Commissioner Janez Potocnik hailed the FP7's approval as 'great day' for European Science. 'In financial terms, this is a major improvement over the last framework programme. In real terms, there are 40 per cent more funds on average per year,' he said.

FP7 will aim to build on the accomplishments of the previous research framework programme, and will be implemented through four specific programmes. The 'Cooperation' programme will support research cooperation in a number of key thematic areas. 'Ideas' will fund investigator-driven research through a newly created European Research Council (ERC). The 'People' programme will support training and researchers' career development, while 'Capacities' will fund the coordination and development of research infrastructure, regional research clusters, international cooperation and closer ties between science and society.

Featuring simpler instruments and streamlined procedures for funding and participation, FP7 should facilitate the greater participation by and cooperation between universities, research centres, small and medium sized enterprises (SMEs) and companies on a broad range of research areas. In doing so, the new programme should make headway on the goal of creating a European Research Area (ERA) - the equivalent of a 'common market' for research - to become the world's leading research area.

Under FP7, the highest portion of the budget will go to information and communication technologies (€9.11 billion), followed by health (€6.05 billion), transport (€4.18 billion) and nanotechnology (€3.5 billion), energy (€2.3 billion), and food, agriculture and biotechnology (€1.935 billion). Other budget lines include environmental research (€1.8 billion), space (€1.43 billion), security (€1.35 billion), and social-economic sciences and humanities (€610 million).

Political discussions on FP7 were first held back by the lack of agreement on the EU's financial perspectives for 2007 to 2013. Consensus among the EU's Heads of State and Government on the overall budget was needed before the FP7 budget could be set.

Subsequent negotiations addressed ethical questions related to EU funding for human embryonic stem cell research, the structure of the ERC and the risk-sharing finance facility.

For further information, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...